PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPLICATIONS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the field of biopharmaceuticals, providing promising developments throughout several medical and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA presents a safer, extra trusted substitute for therapeutic use, sign